Greencross has suspended the operation of its dividend reinvestment plan (DRP) until further notice and the DRP will not apply to the upcoming final dividend for FY2017
Greencross has suspended the operation of its dividend reinvestment plan (DRP) until further notice and the DRP will not apply to the upcoming final dividend for FY2017. The company will release its FY2017 full year results on 22 August 2017. Recently, Animates (Company operates under the brand name of Animates in New Zealand) has completed the acquisition of four veterinary clinics in Auckland for cash consideration of NZ$4.1 million, and these clinics are located inside the Animates retail stores at Botany, Glenfield, Henderson and Takanini. The clinics are expected to contribute annualized revenue of over NZ$3.3 million and annualized EBITDA of approximately NZ$0.6 million. Following the acquisition, currently, Animates network in New Zealand comprises 15 veterinary clinics and 39 retail stores. In addition to the 4 in-store clinics acquired in Auckland, the company has opened 8 in-store clinics in FY2017, while 10 in-store clinics under construction. As a result, Greencross now expects to add a total of 22 in-store clinics to its network in FY2017, which will bring the total number of in-store clinics across Australia and New Zealand to 39. Greencross has opened a further 3 stores in H2 FY2017 at Woolloongabba (QLD), Invercargill (NZ) and Whanganui (NZ). Further, it has opened 19 retail stores, so far in FY2017, bringing the total number of retail stores in the network to 240.
To read the complete report CLICK HERE. To get your free report CLICK HERE
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkine.com.au and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.